In Landmark Study, Immunotherapy Boosts Survival of Advanced Hodgkin Lymphoma
A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92 percent, suggesting a new standard therapy for the ...